参考文献/References:
［1］ Hoole SP，Bambrough P. Recent advances in percutaneous coronary intervention［J］. Heart， 2020， 106：1380- 1386.
［2］ Alexander JH，Wojdyla D，Vora AN，et al. Risk/beneft tradeof of antithrombotic therapy in patients with atrial fbrillation early and late after an acute coronary syndrome or percutaneous coronary intervention： insights from AUGUSTUS［J］. Circulation， 2020，141：1618- 1627.
［3］ Alfonso F，Perez- Vizcayno MJ，Cuesta J，et al. 3- year clinical follow- up of the RIBS Ⅳ clinical trial：a prospective randomized study of drug- eluting balloons versus everolimuseluting stents in patients with in- stent restenosis in coronary arteries previously treated with drug- eluting stents［J］. JACC Cardiovasc Interv， 2018， 11：981- 991.
［4］ Picard F，Doucet S，Asgar AW. Contemporary use of drug- coated balloons in coronary artery disease： where are we now?［J］. Arch Cardiovasc Dis， 2017， 110：259- 272.
［5］ 谢孟君，王春芝，张关禹. 微小核糖核酸- 590与急性冠脉综合征介入术后1年内支架内再狭窄的关系［J］. 介入放射学杂志， 2022， 31：69- 73.
［6］ Soran H，Adam S，Mohammad JB，et al. Hypercholesterolaemia- practical information for non- specialists［J］. Arch Med Sci 2018，14：1- 21.
［7］ Sun L，Zong M，Chen C，et al. Low LPA gene kringle Ⅳ- 2 repeat copy number association with elevated lipoprotein（a） concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population［J］. Lipids Health Dis， 2018， 17：111.
［8］ Nordestgaard BG， Chapman MJ， Ray K， et al.Lipoprotein（a） as a cardiovascular risk factor： current status［J］. Eur Heart J， 2010， 31：2844-2853.
［9］ Saeed A，Virani SS.Lipoprotein（a） and cardiovascular disease： current state and future directions for an enigmatic lipoprotein［J］. Front Biosci，2018，23：1099- 1112.
［10］ Buccheri D，Piraino D， Andolina G， et al.Under standing and managing in- stent restenosis： a review of clinical data， from pathogenesis to treatment［J］. J Thorac Dis， 2016， 8：E1150- E1162.
［11］ Dhar I，Svingen GFT，Pedersen ER，et al. Plasma cystathionine and risk of acute myocardial infarction among patients with coronary heart disease： results from two independent cohorts［J］. Int J Cardiol， 2018， 266：24- 30.
［12］ Kubota Y，Alonso A，Heckbert SR，et al. Homocysteine and incident atrial fibrillation： the atherosclerosis risk in communities study and the multi- ethnic study of atherosclerosis［J］. Heart Lung Circ， 2019， 28：615- 622.
［13］ Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke： a meta- analysis［J］. JAMA， 2002， 288：2015-20 22.
［14］ Chen L，Wang B，Wang J，et al. Association between serum total homocysteine and arterial stiffness in adults： a community- based study［J］. J Clin Hypertens（Greenwich）， 2018， 20：686- 693.
［15］ Yu Y， Zhou Y， Ma Q， et al. The conical stent in coronary artery improves hemodynamics compared with the traditional cylindrical stent［J］. Int J Cardiol， 2017， 227：166- 171.
［16］ Goel SS，Dilip Gajulapalli R，Athappan G，et al. Management of drug eluting stent in- stent restenosis： a systematic review and meta- analysis［J］. Catheter Cardiovasc Interv， 2016， 87：1080- 1091.
［17］ Byrne RA，Joner M，Kastrati A. Stent thrombosis and restenosis： what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014［J］. Eur Heart J， 2015， 36：3320- 3331.
［18］ Dangas GD，Claessen BE，Caixeta A，et al. In- stent restenosis in the drug- eluting stent era［J］. J Am Coll Cardiol， 2010， 56：1897- 1907.
［19］ Cassese S，Byrne RA，Tada T，et al. Incidence and predictors of restenosis after coronary stenting in 10004 patients with surveil-lance angiography［J］. Heart， 2014， 100：153- 159.
［20］ Mansour OY，Ibrahim A，Talaat M. Restenosis predictors after carotid angioplasty and stenting and its influence on procedure durability， single- center experience［J］. J Stroke Cerebrovasc Dis， 2017， 26：2215- 2222.
［21］ Alfonso F，Byrne RA，Rivero F，et al. Current treatment of invstent restenosis［J］. J Am Coll Cardiol， 2014， 63： 2659- 2673.
［22］ 钟继明，黄学成，张景昌，等. 冠状动脉雷帕霉素涂层支架植入术后支架内再狭窄临床预测因素探讨［J］. 介入放射学杂志，2017， 26：874- 877.
［23］ Cheng G，Chang FJ，Wang Y，et al. Factors influencing stent restenosis after percutaneous coronary intervention in patients with coronary heart disease： a clinical trial based on 1- year follow- up［J］. Med Sci Monit， 2019， 25：240- 247.
相似文献/References:
[1]梅百强,杨希立,许兆延,等.H型高血压患者斑块特征与同型半胱氨酸相关性研究 [J].介入放射学杂志,2016,(01):70.
MEI Bai- qiang,YANG Xi- li,XU Zhao- yan,et al.Study on the relationship between plaque imaging characteristics and homocysteine in patients with H- type hypertension [J].journal interventional radiology,2016,(06):70.
[2]钟继明,黄学成,张景昌,等.冠状动脉雷帕霉素涂层支架植入术后支架内再狭窄临床预测因素探讨 [J].介入放射学杂志,2017,(10):874.
ZHONG Jiming,HUANG Xuecheng,ZHANG Jingchang,et al.Investigation of the clinical predictors of in- stent restenosis after rapamycin- eluting coronary stent implantation[J].journal interventional radiology,2017,(06):874.